Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
337 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (17)
  • (-) Currently Recruiting (3)
  • Closed (14)

Medical Condition

  • Show all (337)
  • Addiction (4)
  • Allergy, Asthma, & Immunology (1)
  • Autoimmune Disorders (2)
  • Blood Disorders (2)
  • Bone & Muscle (2)
  • Cancer (93)
  • COVID-19 (Coronavirus) (8)
  • Diabetes (6)
  • Ear, Nose and Throat (6)
  • Endocrine & Metabolic Disease (1)
  • Gastrointestinal and Digestive Diseases (6)
  • Hair and Skin Disorders (1)
  • Healthy Volunteers (47)
  • Heart Disease (23)
  • Infectious Disease (11)
  • Liver Disease (13)
    • (-) Cirrhosis of the Liver (2)
    • Liver Failure (1)
  • Lung Disease (2)
  • Neurological Disorders (46)
    • Alzheimer's Disease (8)
    • Brain Tumors (12)
    • Cerebral Palsy (2)
    • Dementia (3)
    • Huntington's Disease (2)
    • Multiple Sclerosis (4)
    • Neuromuscular (2)
    • (-) Neuropathy (1)
    • Parkinson's Disease (2)
  • Obesity (7)
  • Obstetrics & Gynecology (12)
  • Pediatrics (22)
  • Psychiatric Disorders (4)
  • Rehabilitation (1)
  • Stroke (1)
  • Transplant (15)
  • Vascular Conditions (1)
Displaying 1 - 3 of 3

Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (RESCU)

Condition: Liver Disease / Cirrhosis of the Liver
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
The purpose of this research study is to determine whether rosuvastatin is safe and can help people living with cirrhosis lead longer, healthier lives. The study drug, rosuvastatin, is investigational, meaning it has not yet been approved for market use for this disease condition by the United States Food and Drug Administration (FDA). Participants will…
Read More

A Study to Test the Effects and Safety of Riliprubart in People with Chronic CIDP for Which the Usual Treatment Does Not Work

Condition: Neurological Disorders / Neuropathy
Investigator: Thomas Brannagan, MD
Status: Currently Recruiting
This is a global, multicenter, placebo-controlled, phase 3 study evaluating the efficacy and safety of riliprubart in adult participants with CIDP who are refractory or had an insufficient response to standard of care (SOC) therapies, defined as Ig administered IV (IVIg) or SC (SCIg), or corticosteroids. Treatment duration will be 48 weeks. Participant must…
Read More

Liver Cirrhosis Network (LCN) Cohort Study

Condition: Liver Disease / Cirrhosis of the Liver
Investigator: Elizabeth Verna, MD
Status: Currently Recruiting
LCN Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months for a total of 3 years. Some of the visit…
Read More
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Contact RecruitMe Terms of Use Privacy Policy ©2025 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science